Caredx announces closure of doj investigation with no finding of wrongdoing

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the department of justice (doj) has concluded its investigation into caredx with no finding of wrongdoing and declined to take any further action. in a court document unsealed on october.
CDNA Ratings Summary
CDNA Quant Ranking